Impact of Early Supportive Care Assessment on treatment decision in head and neck cancer before concomitant chemoradiotherapy

Impact of Early Supportive Care Assessment on treatment decision in head and neck cancer before concomitant chemoradiotherapy

Objective: To assess the impact of a global pretherapeutic comprehensive supportive care assessment performed in an outpatient supportive care clinic (OSCC) and early supportive care interventions on oncological treatment choice in patients with chemoradiation (CRT) indication for head and neck canc...

Full description

Bibliographic Details
Main Authors:	Bisiaux, F. (Author), Cherifi, F. (Author), Johnson, A. (Author), Rambeau, A. (Author), Solem Laviec, H. (Author), Villemin, M. (Author)
Format:	Article
Language:	English
Published:	Springer Science and Business Media Deutschland GmbH 2022
Subjects:	Chemoradiotherapy Frailty comprehensive assessment Head and Neck Cancer outpatient clinic Supportive care
Online Access:	View Fulltext in Publisher

Similar Items

Spectrum of fungal infection in head and neck cancer patients on chemoradiotherapy
by: Gunjesh Kumar Singh, et al.
Published: (2017-03-01)

Progressive resistance training in head and neck cancer patients during concomitant chemoradiotherapy -- design of the DAHANCA 31 randomized trial
by: Camilla K. Lonkvist, et al.
Published: (2017-06-01)

The Impact of Active Nutritional Support for Head and Neck Cancer Patients Receiving Concurrent Chemoradiotherapy
by: Vutisiri Veerasarn, et al.
Published: (2019-12-01)

Nephrotoxicity as a Dose-Limiting Factor in a High-Dose Cisplatin-Based Chemoradiotherapy Regimen for Head and Neck Carcinomas
by: Jantien Hoek, et al.
Published: (2016-02-01)

Prognostic Significance of Sarcopenia With Inflammation in Patients With Head and Neck Cancer Who Underwent Definitive Chemoradiotherapy
by: Yeona Cho, et al.
Published: (2018-10-01)

Risk factors for aspiration pneumonia during concurrent chemoradiotherapy or bio-radiotherapy for head and neck cancer
by: Hiromichi Shirasu, et al.
Published: (2020-03-01)

Nutritional support as an obligatory component of accompanying therapy for head and neck tumors during radiotherapy and chemoradiotherapy
by: A. V. Boyko, et al.
Published: (2017-04-01)

Survival benefits from concomitant chemoradiotherapy before radical surgery in stage IVA sinonasal mucosal melanoma?
by: Anna Hafström, et al.
Published: (2019-12-01)

Outcome in radiographic complete regression of unresectable head and neck cancer with carotid artery encasement from induction chemotherapy followed by concurrent chemoradiotherapy: Case reports
by: Federico Ampil, et al.
Published: (2019-06-01)

Nutritional Care in Patients with Head and Neck Cancer during Chemoradiotherapy (CRT) and Bioradiotherapy (BRT) Provides Better Compliance with the Treatment Plan
by: Aleksandra Kapała, et al.
Published: (2021-05-01)

Comparison of Carboplatin With 5-Fluorouracil vs. Cisplatin as Concomitant Chemoradiotherapy for Locally Advanced Head and Neck Squamous Cell Carcinoma
by: Saskia H. Hanemaaijer, et al.
Published: (2020-06-01)

Safety and efficacy of concurrent chemoradiotherapy for head-and-neck cancers in older versus younger patients: Post hoc analysis of a randomized controlled trial
by: Gunjesh Kumar Singh, et al.
Published: (2020-01-01)

Immune Check-Point Inhibitors and Standard Chemoradiotherapy in Definitive Head and Neck Cancer Treatment
by: Francesca De Felice, et al.
Published: (2021-05-01)

Primary Concurrent Chemoradiation in Head and Neck Cancers with Weekly Cisplatin Chemotherapy: Analysis of Compliance, Toxicity and Survival
by: Muhammad Shahid Iqbal, et al.
Published: (2017-04-01)

Can zinc supplementation widen the gap between control and complications in head and neck cancer patients treated with concurrent chemo-radiotherapy
by: Mohsin Khan, et al.
Published: (2019-01-01)

Low-Dose vs. High-Dose Cisplatin: Lessons Learned From 59 Chemoradiotherapy Trials in Head and Neck Cancer
by: Petr Szturz, et al.
Published: (2019-02-01)

Feasibility of concomitant cisplatin with hypofractionated radiotherapy for locally advanced head and neck squamous cell carcinoma
by: Alexandre Arthur Jacinto, et al.
Published: (2018-10-01)

Efficacy of Different Chemotherapy Regimens in Patients with Locally Advanced Synchronous Esophageal and Head/Neck Squamous Cell Carcinoma Receiving Curative Concurrent Chemoradiotherapy
by: Yen-Hao Chen, et al.
Published: (2020-01-01)

Prognostic role of diffusion weighted and dynamic contrast-enhanced MRI in loco-regionally advanced head and neck cancer treated with concomitant chemoradiotherapy
by: Garbajs Manca, et al.
Published: (2019-03-01)

A phase II randomized trial comparing neoadjuvant chemotherapy followed by concurrent chemoradiotherapy versus concurrent chemoradiotherapy alone in advanced squamous cell carcinoma of the pharynx or larynx
by: Pei-Wei Huang, et al.
Published: (2018-04-01)

Low-level laser therapy in treatment of chemoradiotherapy-induced mucositis in head and neck cancer: results of a randomised, triple blind, multicentre phase III trial
by: Florence Legouté, et al.
Published: (2019-05-01)

Paclitaxel Plus Cetuximab as 1st Line Chemotherapy in Platinum-Based Chemoradiotherapy-Refractory Patients With Squamous Cell Carcinoma of the Head and Neck
by: Tomohiro Enokida, et al.
Published: (2018-08-01)

A Retrospective Study of Reirradiation for Patients with Locoregional Recurrent Head and Neck Cancer: A Single-Institution Experience
by: Dina Salem, et al.
Published: (2016-06-01)

Topical steroid versus placebo for the prevention of radiation dermatitis in head and neck cancer patients receiving chemoradiotherapy: the study protocol of J-SUPPORT 1602 (TOPICS study), a randomized double-blinded phase 3 trial
by: Sadamoto Zenda, et al.
Published: (2018-09-01)

Nutritional Interventions in Head and Neck Cancer Patients Undergoing Chemoradiotherapy: A Narrative Review
by: Maurizio Bossola
Published: (2015-01-01)

Impact of Neck Dissection in Head and Neck Squamous Cell Carcinomas of Unknown Primary
by: Yazan Abu-Shama, et al.
Published: (2021-05-01)

Genetic Factors Associated with a Poor Outcome in Head and Neck Cancer Patients Receiving Definitive Chemoradiotherapy
by: David M. Vossen, et al.
Published: (2019-03-01)

Competing Morbidities In Advanced Head And Neck Squamous Cell Carcinoma Concurrent Chemoradiotherapy: A Strong Implication Of A Multidisciplinary Team Approach
by: Lazzari G, et al.
Published: (2019-11-01)

Skull base or cervical vertebral osteomyelitis following chemoradiotherapy for pharyngeal carcinoma: A serious but treatable complication
by: Nafisha Lalani, et al.
Published: (2018-01-01)

Patterns, Predictors, and Prognostic Value of Skeletal Muscle Mass Loss in Patients with Locally Advanced Head and Neck Cancer Undergoing Cisplatin-Based Chemoradiotherapy
by: Najiba Chargi, et al.
Published: (2021-04-01)

Nutritional status and dietary quality index of head and neck cancer patients undergoing chemo radiotherapy
by: Shirin Fattahi, et al.
Published: (2020-02-01)

Oral Complications of Head and Neck Cancer Therapy
by: Kouri Maria, et al.
Published: (2021-08-01)

Reconstruction of the Head and Neck Region Using Lower Trapezius Musculocutaneous Flaps
by: Soo Kwang Yoon, et al.
Published: (2012-11-01)

The Slippery Role of Induction Chemotherapy in Head and Neck Cancer: Myth and Reality
by: Daris Ferrari, et al.
Published: (2020-01-01)

Efficacy and safety of rebamipide liquid for chemoradiotherapy-induced oral mucositis in patients with head and neck cancer: a multicenter, randomized, double-blind, placebo-controlled, parallel-group phase II study
by: T. Yokota, et al.
Published: (2017-05-01)

Identifying risk factors for L’Hermitte’s sign after IMRT for head and neck cancer
by: Hannah M. Laidley, et al.
Published: (2018-05-01)

Concurrent chemoradiotherapy using cisplatin, tegafur, and leucovorin for advanced squamous cell carcinoma of the hypopharynx and oropharynx
by: Hung-Ming Wang, et al.
Published: (2014-06-01)

Cisplatin Eligibility Issues and Alternative Regimens in Locoregionally Advanced Head and Neck Cancer: Recommendations for Clinical Practice
by: Petr Szturz, et al.
Published: (2019-06-01)

Predictors of postradiation swallowing dysfunction in head-and-neck cancer
by: Romi Kant Grover, et al.
Published: (2018-01-01)

A multicenter phase II trial of paclitaxel, carboplatin, and cetuximab followed by chemoradiotherapy in patients with unresectable locally advanced squamous cell carcinoma of the head and neck
by: Tomohiro Enokida, et al.
Published: (2020-03-01)